Levi & Korsinsky announces that a class action lawsuit has been
commenced in the USDC for the Northern District of California on behalf
of investors who purchased or otherwise acquired AcelRx Pharmaceuticals,
Inc. (“AcelRx” or the “Company”) (Nasdaq:ACRX) common stock and/or call
options, or sold/wrote AcelRX’s put options between December 2, 2013 and
September 25, 2014.
for - UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against AcelRx Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 1, 2014 investment picks